Abstract
Clopidogrel (Plavix) is one of the most widely prescribed drugs worldwide. It usually is administered to prevent thrombosis in patients who are undergoing coronary stent placement and in those with cerebral and peripheral ischemic vascular disease. Clopidogrel inhibits the platelet P2Y12 adenosine diphosphate (ADP) receptor, but about 25% of patients who are treated with standard doses of this drug are resistant to its platelet-inhibitory effects. Most importantly, the failure of clopidogrel to inhibit platelet function is associated with high …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
